Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strontium ranelate for knee osteoarthritis (1 g vs 2 g vs placebo)
2005-002494-75Phase 3Completed
- Sponsor
- Servier
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of strontium ranelate in knee osteoarthritis (OA) (3 arms), sponsored by Servier. Primary endpoint: Radiographic progression of knee osteoarthritis. Started Dec 2005; status: completed.
02
Drugs
strontium ranelate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2005-002494-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002494-75.